205 related articles for article (PubMed ID: 1280730)
1. Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action.
Ferrari R; Cargnoni A; Curello S; Ceconi C; Boraso A; Visioli O
J Cardiovasc Pharmacol; 1992; 20(5):694-704. PubMed ID: 1280730
[TBL] [Abstract][Full Text] [Related]
2. Effect of angiotensin converting enzyme inhibition with quinaprilat on the ischaemic and reperfused myocardium.
Cargnoni A; Boraso A; Scotti C; Ghirardelli N; Benigno M; Bernocchi P; Pedersini P; Ferrari R
J Mol Cell Cardiol; 1994 Jan; 26(1):69-86. PubMed ID: 8196071
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channel.
Sargent CA; Sleph PG; Dzwonczyk S; Smith MA; Normandin D; Antonaccio MJ; Grover GJ
J Pharmacol Exp Ther; 1993 May; 265(2):609-18. PubMed ID: 8496812
[TBL] [Abstract][Full Text] [Related]
4. Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion.
Ferrari R; Raddino R; Di Lisa F; Ceconi C; Curello S; Albertini A; Nayler W
J Thorac Cardiovasc Surg; 1990 May; 99(5):919-28. PubMed ID: 2329831
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of gallopamil against ischemia and reperfusion damage.
Ferrari R; Boraso A; Condorelli E; De Giuli F; Pasini E; Cargnoni A; Agnoletti G; Ghielmi S
Z Kardiol; 1989; 78 Suppl 5():1-11. PubMed ID: 2631474
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of the potent Na/H exchange inhibitor methylisobutyl amiloride against post-ischemic contractile dysfunction in rat and guinea-pig hearts.
Moffat MP; Karmazyn M
J Mol Cell Cardiol; 1993 Aug; 25(8):959-71. PubMed ID: 8263964
[TBL] [Abstract][Full Text] [Related]
7. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors.
Liu X; Engelman RM; Rousou JA; Cordis GA; Das DK
Cardiovasc Drugs Ther; 1992 Aug; 6(4):437-43. PubMed ID: 1387799
[TBL] [Abstract][Full Text] [Related]
9. Anti-free radical mechanisms in captopril protection against reperfusion injury in isolated rat hearts.
Anderson B; Khaper N; Dhalla AK; Singal PK
Can J Cardiol; 1996 Oct; 12(10):1099-104. PubMed ID: 9191504
[TBL] [Abstract][Full Text] [Related]
10. Effect of ischemic preconditioning on mitochondrial oxidative phosphorylation and high energy phosphates in rat hearts.
Kobara M; Tatsumi T; Matoba S; Yamahara Y; Nakagawa C; Ohta B; Matsumoto T; Inoue D; Asayama J; Nakagawa M
J Mol Cell Cardiol; 1996 Feb; 28(2):417-28. PubMed ID: 8729072
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of angiotensin I converting enzyme inhibitor on post-ischemic contractile function of perfused rat heart.
Tanonaka K; Kamiyama T; Takezono A; Sakai K; Takeo S
J Mol Cell Cardiol; 1996 Aug; 28(8):1659-70. PubMed ID: 8877776
[TBL] [Abstract][Full Text] [Related]
12. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
Westlin W; Mullane K
Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
[TBL] [Abstract][Full Text] [Related]
13. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
Chen H; Mohuczy D; Li D; Kimura B; Phillips MI; Mehta P; Mehta JL
Gene Ther; 2001 May; 8(10):804-10. PubMed ID: 11420645
[TBL] [Abstract][Full Text] [Related]
14. Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart.
Ceconi C; Cargnoni A; Francolini G; Parinello G; Ferrari R
Cardiovasc Res; 2009 Oct; 84(1):72-82. PubMed ID: 19477966
[TBL] [Abstract][Full Text] [Related]
15. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
[TBL] [Abstract][Full Text] [Related]
16. The effects of L-arginine mono(2-mercaptoethanesulfonate) on the ischemic and reperfused heart.
Cargnoni A; Comini L; Boraso A; De Giuli F; Scotti C; Ferrari R
Cardioscience; 1992 Sep; 3(3):179-87. PubMed ID: 1420954
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury.
Schulz R; Wambolt R
Cardiovasc Res; 1995 Sep; 30(3):432-9. PubMed ID: 7585835
[TBL] [Abstract][Full Text] [Related]
18. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of quinidine on post-ischemic contractile failure of isolated rat hearts.
Liu JX; Tanonaka K; Sanbe A; Yamamoto K; Takeo S
J Mol Cell Cardiol; 1993 Oct; 25(10):1249-63. PubMed ID: 8263956
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant protection against damage during cardiac ischemia and reperfusion: effect of dimercapto-propanol.
Ceconi C; Curello S; Cargnoni A; Boffa GM; Ferrari R
Cardioscience; 1990 Sep; 1(3):191-8. PubMed ID: 2102808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
